Morocco advances in the construction of the second factory in the country in which cannabis will be used for medical purposes.
As the Ministry of Commerce and Industry has revealed, it is an ambitious project with a total cost of 60 million dirhams (about 14.6 million euros).
The industrial warehouse will be built in the Ain Cheggag industrial complex, in the province of Sefrú, in the Fez-Meknes region, and will have an area of 6,000 square meters.
In this context, the ministry indicated that “an agreement protocol was signed to complete an investment project related to a cannabis conversion factory and extraction of materials for use in medical industries.”
Read more on the subject and find other interesting cannabis news from around the world with the Hemp.im mobile app, available for free for both Android and iOS devices.
The Moroccan Parliament approved in June 2021 a law that regulated for the first time the therapeutic and industrial uses of the cannabis plant but punished its “recreational” use
Already in March 2022, the Government gave shape to this regularization with the approval of a decree that determined the cultivation in the northern Al Hoceima, Chefchaouen, and Taunat, as they are the provinces historically known for this activity.
As a high point, on June 3rd of the same year, Morocco announced an “action plan” for the medical and industrial exploitation of cannabis, and in July, a law aimed at legalizing its uses entered into force.
The first factory for the use of cannabis for medical purposes in the country was inaugurated last March in the Bab Bard region, in the Chaouen region.
Managed by the Bio Cannat Cooperative, it thus became the first national unit to exploit this plant for use in the food and pharmaceutical industries.
Now, the ministry has signed an agreement to start the construction of a second plant that helps the Government to continue regularizing the use of cannabis, a whole business in the country, which is postulated as one of the largest producers in the world.
According to a report by the Moroccan Ministry of the Interior, at least 400,000 people belonging to 60,000 humble families live from the cultivation of this plant, generally on small farms in the north.
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in elFAROceuta, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Citi Announced a $6 Million Loan to Sempli for SME financing
The credit granted by Citi was given in partnership with high-impact investors and multilateral development organizations. They all seek to...
How Will the Price of Ripple and Cardano Develop in the Next Few Days
The BOLL indicator shows no specific pattern and denotes the support price of $0.4969 and the resistance price of $0.5059,...
RADEEF: a 182 Million Dirham Plan to Combat Flooding in Morocco
RADEEF is also planning major expansion projects. Firstly, it plans to launch work on extending the wastewater treatment plant. The...
How Institutional Investors Feel About Impact Investing
Investors continue to face greenwashing when implementing impact investing. Among their key concerns are misleading or exaggerated impact claims (60%),...
Crowdfunding1 week ago
Mamacrowd Launches Five Campaigns with November 10th Deadline
Impact Investing2 weeks ago
Why Sustainable Funds Are a Difficult Challenge
Crypto5 days ago
Stanford University Returns Millions from FTX
Business1 week ago
The Soft-Landing Narrative Is a Myth: The US Recession Is Not Canceled